Investigating the Regulation of Reproductive Hormones in Adult Men
Primary Purpose
Kallmann Syndrome, Hypogonadism, Gonadal Disorder
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ketoconazole
gonadotropin releasing hormone (GnRH)
Sponsored by
About this trial
This is an interventional health services research trial for Kallmann Syndrome focused on measuring Idiopathic Hypogonadotropic Hypogonadism, Kallmann Syndrome, Agonadal
Eligibility Criteria
Inclusion Criteria:
- Men aged 18 to 50 years
- In good health
- On no medications
Exclusion Criteria:
Subjects will not be enrolled in this study if there is a history of:
- Liver disease or if screening blood tests demonstrate abnormal liver function tests
- Excessive alcohol consumption
- Illicit drug use
- Severe drug allergy
- Use of any concomitant medications
- Peptic ulcer disease or gastritis
Sites / Locations
- Massachusetts General Hospital
Outcomes
Primary Outcome Measures
serum hormone levels
Secondary Outcome Measures
Full Information
NCT ID
NCT00392457
First Posted
October 25, 2006
Last Updated
February 12, 2015
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1. Study Identification
Unique Protocol Identification Number
NCT00392457
Brief Title
Investigating the Regulation of Reproductive Hormones in Adult Men
Official Title
Feedback Control of FSH Secretion in the Human Male
Study Type
Interventional
2. Study Status
Record Verification Date
April 2010
Overall Recruitment Status
Completed
Study Start Date
July 1995 (undefined)
Primary Completion Date
February 2007 (Actual)
Study Completion Date
February 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
4. Oversight
5. Study Description
Brief Summary
The purpose of the research study is to learn more about the regulation of reproductive hormones in adult men. We would like to understand what role testosterone and estradiol play in controlling the release of LH (lutenizing hormone) and FSH (follicle stimulating hormone). Testosterone and estradiol come from the testes, and LH and FSH are released from a gland in the head called the pituitary.
Men involved in the study will have detailed evaluations that involve overnight stays in the hospital and frequent blood sampling. The men in the study will also be receiving medications that affect the levels of various hormones in the body. This will allow the researchers to learn how various hormones influence each other. Men that participate in the study will receive medical evaluations and monetary compensation. Information gathered from this study will help in the development of new treatments for infertility and potentially new hormonal forms of contraception.
Detailed Description
In the United States 10-15% couples seek evaluation for infertility, of whom a male factor is identified in approximately 50% of cases. To date, however, most infertility research has focused on the female partner and in the majority of instances the etiology of male infertility remains poorly understood with inconsistent elevation in FSH levels. Given that spermatogenesis is highly dependent on FSH secretion, this project will focus on delineating the feedback control of FSH in the human male. Such studies, although difficult to perform in the human, are critical to understanding not only the pathophysiology of male infertility, but also to determining the feasibility of hormonal approaches to male contraception. In this protocol, studies of normal, GnRH-deficient and agonadal men employing reversible sex steroid ablation, physiologic sex steroid replacement and manipulation of the GnRH input to the pituitary will permit the non-steroidal, sex steroid, and GnRH-dependent components of FSH regulation to be selectively elucidated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kallmann Syndrome, Hypogonadism, Gonadal Disorder
Keywords
Idiopathic Hypogonadotropic Hypogonadism, Kallmann Syndrome, Agonadal
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
175 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
ketoconazole
Intervention Description
loading dose of 1g followed by a maintenance dose of 400 mg PO QID for 7 days
Intervention Type
Drug
Intervention Name(s)
gonadotropin releasing hormone (GnRH)
Intervention Description
Pulsatile GnRH (25 ng/kg per bolus every two hours via microinfusion pump titrated to reach normal serum testosterone levels)
Primary Outcome Measure Information:
Title
serum hormone levels
Time Frame
Baseline, Day 3, and Day 6
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Men aged 18 to 50 years
In good health
On no medications
Exclusion Criteria:
Subjects will not be enrolled in this study if there is a history of:
Liver disease or if screening blood tests demonstrate abnormal liver function tests
Excessive alcohol consumption
Illicit drug use
Severe drug allergy
Use of any concomitant medications
Peptic ulcer disease or gastritis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William F Crowley, Jr., MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114-2696
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
7816068
Citation
Howards SS. Treatment of male infertility. N Engl J Med. 1995 Feb 2;332(5):312-7. doi: 10.1056/NEJM199502023320507. No abstract available.
Results Reference
background
PubMed Identifier
3136011
Citation
Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 1988 May;9(2):267-93. doi: 10.1210/edrv-9-2-267.
Results Reference
background
PubMed Identifier
7714112
Citation
Khoury RH, Wang QF, Crowley WF Jr, Hall JE, Schneyer AL, Toth T, Midgley AR Jr, Sluss PM. Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab. 1995 Apr;80(4):1361-8. doi: 10.1210/jcem.80.4.7714112.
Results Reference
background
PubMed Identifier
9626105
Citation
Hayes FJ, Hall JE, Boepple PA, Crowley WF Jr. Clinical review 96: Differential control of gonadotropin secretion in the human: endocrine role of inhibin. J Clin Endocrinol Metab. 1998 Jun;83(6):1835-41. doi: 10.1210/jcem.83.6.4884.
Results Reference
background
PubMed Identifier
1104659
Citation
Santen RJ. Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men? J Clin Invest. 1975 Dec;56(6):1555-63. doi: 10.1172/JCI108237.
Results Reference
background
PubMed Identifier
372203
Citation
Winters SJ, Janick JJ, Loriaux DL, Sherins RJ. Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. II. Use of the estrogen antagonist, clomiphene citrate. J Clin Endocrinol Metab. 1979 Feb;48(2):222-7. doi: 10.1210/jcem-48-2-222. No abstract available.
Results Reference
background
PubMed Identifier
6421864
Citation
Matsumoto AM, Bremner WJ. Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab. 1984 Apr;58(4):609-14. doi: 10.1210/jcem-58-4-609.
Results Reference
background
PubMed Identifier
1908484
Citation
Finkelstein JS, Whitcomb RW, O'Dea LS, Longcope C, Schoenfeld DA, Crowley WF Jr. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991 Sep;73(3):609-20. doi: 10.1210/jcem-73-3-609.
Results Reference
background
PubMed Identifier
1908485
Citation
Finkelstein JS, O'Dea LS, Whitcomb RW, Crowley WF Jr. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991 Sep;73(3):621-8. doi: 10.1210/jcem-73-3-621.
Results Reference
background
PubMed Identifier
8188534
Citation
Bagatell CJ, Dahl KD, Bremner WJ. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. J Androl. 1994 Jan-Feb;15(1):15-21.
Results Reference
background
PubMed Identifier
8636341
Citation
Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996 Apr;81(4):1401-5. doi: 10.1210/jcem.81.4.8636341.
Results Reference
background
PubMed Identifier
7720645
Citation
Majumdar SS, Mikuma N, Ishwad PC, Winters SJ, Attardi BJ, Perera AD, Plant TM. Replacement with recombinant human inhibin immediately after orchidectomy in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) maintains follicle-stimulating hormone (FSH) secretion and FSH beta messenger ribonucleic acid levels at precastration values. Endocrinology. 1995 May;136(5):1969-77. doi: 10.1210/endo.136.5.7720645.
Results Reference
background
PubMed Identifier
3145231
Citation
Culler MD, Negro-Vilar A. Passive immunoneutralization of endogenous inhibin: sex-related differences in the role of inhibin during development. Mol Cell Endocrinol. 1988 Aug;58(2-3):263-73. doi: 10.1016/0303-7207(88)90163-3.
Results Reference
background
PubMed Identifier
3008572
Citation
Veldhuis JD, Johnson ML. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 1986 Apr;250(4 Pt 1):E486-93. doi: 10.1152/ajpendo.1986.250.4.E486.
Results Reference
background
PubMed Identifier
6276122
Citation
Heel RC, Brogden RN, Carmine A, Morley PA, Speight TM, Avery GS. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs. 1982 Jan-Feb;23(1-2):1-36. doi: 10.2165/00003495-198223010-00001. No abstract available.
Results Reference
background
PubMed Identifier
6093722
Citation
Pont A, Graybill JR, Craven PC, Galgiani JN, Dismukes WE, Reitz RE, Stevens DA. High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med. 1984 Nov;144(11):2150-3.
Results Reference
background
PubMed Identifier
3306384
Citation
Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med. 1987 Sep 24;317(13):812-8. doi: 10.1056/NEJM198709243171307. No abstract available.
Results Reference
background
PubMed Identifier
6151171
Citation
Van Tyle JH. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy. 1984 Nov-Dec;4(6):343-73. doi: 10.1002/j.1875-9114.1984.tb03398.x.
Results Reference
background
PubMed Identifier
6319220
Citation
Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology. 1984 Mar;86(3):503-13.
Results Reference
background
PubMed Identifier
6324708
Citation
Duarte PA, Chow CC, Simmons F, Ruskin J. Fatal hepatitis associated with ketoconazole therapy. Arch Intern Med. 1984 May;144(5):1069-70.
Results Reference
background
PubMed Identifier
6315129
Citation
van Dijke CP, Veerman FR, Haverkamp HC. Anaphylactic reactions to ketoconazole. Br Med J (Clin Res Ed). 1983 Dec 3;287(6406):1673. doi: 10.1136/bmj.287.6406.1673. No abstract available.
Results Reference
background
PubMed Identifier
6129799
Citation
Janssen PA, Symoens JE. Hepatic reactions during ketoconazole treatment. Am J Med. 1983 Jan 24;74(1B):80-5. doi: 10.1016/0002-9343(83)90519-3.
Results Reference
background
PubMed Identifier
18073301
Citation
Pitteloud N, Dwyer AA, DeCruz S, Lee H, Boepple PA, Crowley WF Jr, Hayes FJ. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 2008 Mar;93(3):784-91. doi: 10.1210/jc.2007-2156. Epub 2007 Dec 11.
Results Reference
result
PubMed Identifier
18270253
Citation
Boepple PA, Hayes FJ, Dwyer AA, Raivio T, Lee H, Crowley WF Jr, Pitteloud N. Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function. J Clin Endocrinol Metab. 2008 May;93(5):1809-14. doi: 10.1210/jc.2007-2450. Epub 2008 Feb 12.
Results Reference
result
PubMed Identifier
18445673
Citation
Pitteloud N, Dwyer AA, DeCruz S, Lee H, Boepple PA, Crowley WF Jr, Hayes FJ. The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men. J Clin Endocrinol Metab. 2008 Jul;93(7):2686-92. doi: 10.1210/jc.2007-2548. Epub 2008 Apr 29.
Results Reference
result
Links:
URL
http://www.massgeneral.org/reproendo/pages/reu_study_subject.htm
Description
Clinical research studies of the Reproductive Endocrine Unit at the Massachusetts General Hospital. Click here for more information about this study: Feedback Control of FSH Secretion in the Human Male
Learn more about this trial
Investigating the Regulation of Reproductive Hormones in Adult Men
We'll reach out to this number within 24 hrs